Partnerships & Mergers

The collaboration is designed to strengthen Everest’s commercial operations in China while expanding its presence in the cardiovascular disease market.

The collaboration reinforces Bupa CareConnect’s leadership in the Kingdom’s digital healthcare transformation and aligns with the national objectives of Saudi Vision 2030.

The partnership is built on five guiding principles: Member State Ownership and Leadership, Equity and Access, Sustainability and Sovereignty, Transparency and Accountability, and Innovation for Impact.

The collaboration brings together IROS’s clinical research expertise with BioSapien’s innovative cancer treatment technology to advance precision medicine in the region.

The management contract forms part of Seha Group’s broader expansion strategy, which emphasizes development and operational excellence rather than traditional acquisition models.

AGC Biologics now offers the ATUM transposase-based platform as part of its growing portfolio of cell line development solutions.

The partnership will begin with a study focused on assessing Mirai’s ability to predict breast cancer risk specifically in Japanese women using mammography images.

The two pharmaceutical giants originally signed the agreement in October 2025, establishing a framework centered on bispecific antibodies and ADCs.

The clinic addresses a critical need revealed by hospital data showing that 20% of burn cases directly result from violence against women.

Regeneron is investing USD 150 million in equity and upfront payments to acquire half of the global development and commercialization rights for TSRA-196.